nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—multiple sclerosis	0.264	1	CbGaD
Vismodegib—ABCG2—Cladribine—multiple sclerosis	0.0798	0.148	CbGbCtD
Vismodegib—ABCG2—Mitoxantrone—multiple sclerosis	0.0582	0.108	CbGbCtD
Vismodegib—ALB—Prednisone—multiple sclerosis	0.0333	0.062	CbGbCtD
Vismodegib—ABCG2—Dexamethasone—multiple sclerosis	0.0302	0.0561	CbGbCtD
Vismodegib—ABCB1—Methylprednisolone—multiple sclerosis	0.0288	0.0535	CbGbCtD
Vismodegib—CYP3A4—Fingolimod—multiple sclerosis	0.0268	0.0498	CbGbCtD
Vismodegib—ABCG2—Methotrexate—multiple sclerosis	0.0243	0.0451	CbGbCtD
Vismodegib—CYP2C19—Prednisone—multiple sclerosis	0.0216	0.0402	CbGbCtD
Vismodegib—ABCB1—Mitoxantrone—multiple sclerosis	0.021	0.039	CbGbCtD
Vismodegib—ABCB1—Betamethasone—multiple sclerosis	0.0187	0.0348	CbGbCtD
Vismodegib—ABCB1—Prednisolone—multiple sclerosis	0.0185	0.0343	CbGbCtD
Vismodegib—ABCB1—Prednisone—multiple sclerosis	0.0174	0.0324	CbGbCtD
Vismodegib—CYP3A4—Methylprednisolone—multiple sclerosis	0.0172	0.0321	CbGbCtD
Vismodegib—ALB—Methotrexate—multiple sclerosis	0.0167	0.0311	CbGbCtD
Vismodegib—CYP2C8—Dexamethasone—multiple sclerosis	0.0161	0.0299	CbGbCtD
Vismodegib—CYP2C19—Dexamethasone—multiple sclerosis	0.0135	0.0251	CbGbCtD
Vismodegib—CYP3A4—Triamcinolone—multiple sclerosis	0.0131	0.0243	CbGbCtD
Vismodegib—CYP3A4—Mitoxantrone—multiple sclerosis	0.0126	0.0234	CbGbCtD
Vismodegib—CYP2C9—Dexamethasone—multiple sclerosis	0.0112	0.0209	CbGbCtD
Vismodegib—CYP3A4—Betamethasone—multiple sclerosis	0.0112	0.0208	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—multiple sclerosis	0.0111	0.0206	CbGbCtD
Vismodegib—ABCB1—Dexamethasone—multiple sclerosis	0.0109	0.0202	CbGbCtD
Vismodegib—CYP3A4—Prednisone—multiple sclerosis	0.0104	0.0194	CbGbCtD
Vismodegib—ABCB1—Methotrexate—multiple sclerosis	0.00875	0.0163	CbGbCtD
Vismodegib—CYP3A4—Dexamethasone—multiple sclerosis	0.00652	0.0121	CbGbCtD
Vismodegib—Potassium low—Mitoxantrone—multiple sclerosis	0.00433	0.0502	CcSEcCtD
Vismodegib—SHH—brainstem—multiple sclerosis	0.00358	0.115	CbGeAlD
Vismodegib—Hepatic enzyme increased—Fingolimod—multiple sclerosis	0.00257	0.0298	CcSEcCtD
Vismodegib—Blood potassium decreased—Mitoxantrone—multiple sclerosis	0.00238	0.0277	CcSEcCtD
Vismodegib—SHH—midbrain—multiple sclerosis	0.00228	0.0735	CbGeAlD
Vismodegib—SHH—spinal cord—multiple sclerosis	0.00223	0.0717	CbGeAlD
Vismodegib—SHH—nervous system—multiple sclerosis	0.00188	0.0604	CbGeAlD
Vismodegib—SHH—central nervous system—multiple sclerosis	0.00181	0.0582	CbGeAlD
Vismodegib—Blood potassium decreased—Methylprednisolone—multiple sclerosis	0.00179	0.0208	CcSEcCtD
Vismodegib—SHH—cerebellum—multiple sclerosis	0.00177	0.0569	CbGeAlD
Vismodegib—SMO—medulla oblongata—multiple sclerosis	0.00175	0.0563	CbGeAlD
Vismodegib—Neoplasm malignant—Cladribine—multiple sclerosis	0.00161	0.0187	CcSEcCtD
Vismodegib—SMO—midbrain—multiple sclerosis	0.0016	0.0514	CbGeAlD
Vismodegib—Aspartate aminotransferase increased—Fingolimod—multiple sclerosis	0.00159	0.0185	CcSEcCtD
Vismodegib—SMO—spinal cord—multiple sclerosis	0.00156	0.0502	CbGeAlD
Vismodegib—SHH—brain—multiple sclerosis	0.00143	0.0462	CbGeAlD
Vismodegib—Blood potassium decreased—Prednisone—multiple sclerosis	0.00142	0.0165	CcSEcCtD
Vismodegib—Musculoskeletal pain—Cladribine—multiple sclerosis	0.0014	0.0162	CcSEcCtD
Vismodegib—Weight decreased—Fingolimod—multiple sclerosis	0.00138	0.016	CcSEcCtD
Vismodegib—Neoplasm malignant—Azathioprine—multiple sclerosis	0.00131	0.0152	CcSEcCtD
Vismodegib—SMO—nervous system—multiple sclerosis	0.00131	0.0423	CbGeAlD
Vismodegib—SMO—central nervous system—multiple sclerosis	0.00126	0.0407	CbGeAlD
Vismodegib—SMO—cerebellum—multiple sclerosis	0.00124	0.0398	CbGeAlD
Vismodegib—Connective tissue disorder—Fingolimod—multiple sclerosis	0.0012	0.0139	CcSEcCtD
Vismodegib—Alopecia—Fingolimod—multiple sclerosis	0.00108	0.0125	CcSEcCtD
Vismodegib—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.00103	0.012	CcSEcCtD
Vismodegib—Back pain—Fingolimod—multiple sclerosis	0.00103	0.0119	CcSEcCtD
Vismodegib—SMO—brain—multiple sclerosis	0.001	0.0323	CbGeAlD
Vismodegib—Pain in extremity—Cladribine—multiple sclerosis	0.001	0.0116	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.000958	0.0111	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.000899	0.0104	CcSEcCtD
Vismodegib—Blood urea increased—Mitoxantrone—multiple sclerosis	0.000856	0.00993	CcSEcCtD
Vismodegib—Nervous system disorder—Fingolimod—multiple sclerosis	0.000851	0.00988	CcSEcCtD
Vismodegib—Azotaemia—Methotrexate—multiple sclerosis	0.000848	0.00984	CcSEcCtD
Vismodegib—Skin disorder—Fingolimod—multiple sclerosis	0.000843	0.00978	CcSEcCtD
Vismodegib—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.000777	0.00901	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000749	0.00869	CcSEcCtD
Vismodegib—Fatigue—Fingolimod—multiple sclerosis	0.000748	0.00868	CcSEcCtD
Vismodegib—Amenorrhoea—Dexamethasone—multiple sclerosis	0.000706	0.00819	CcSEcCtD
Vismodegib—Amenorrhoea—Betamethasone—multiple sclerosis	0.000706	0.00819	CcSEcCtD
Vismodegib—ORM1—spinal cord—multiple sclerosis	0.000681	0.0219	CbGeAlD
Vismodegib—Connective tissue disorder—Cladribine—multiple sclerosis	0.000681	0.0079	CcSEcCtD
Vismodegib—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.000661	0.00767	CcSEcCtD
Vismodegib—Asthenia—Fingolimod—multiple sclerosis	0.000623	0.00723	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—multiple sclerosis	0.000615	0.00714	CcSEcCtD
Vismodegib—Pruritus—Fingolimod—multiple sclerosis	0.000614	0.00713	CcSEcCtD
Vismodegib—Alopecia—Cladribine—multiple sclerosis	0.000612	0.0071	CcSEcCtD
Vismodegib—Dehydration—Mitoxantrone—multiple sclerosis	0.000612	0.0071	CcSEcCtD
Vismodegib—Malnutrition—Cladribine—multiple sclerosis	0.000603	0.00699	CcSEcCtD
Vismodegib—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.000601	0.00697	CcSEcCtD
Vismodegib—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000599	0.00695	CcSEcCtD
Vismodegib—Diarrhoea—Fingolimod—multiple sclerosis	0.000594	0.00689	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000593	0.00688	CcSEcCtD
Vismodegib—Back pain—Cladribine—multiple sclerosis	0.000583	0.00677	CcSEcCtD
Vismodegib—ORM1—nervous system—multiple sclerosis	0.000574	0.0185	CbGeAlD
Vismodegib—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.000569	0.00661	CcSEcCtD
Vismodegib—ORM1—central nervous system—multiple sclerosis	0.000552	0.0178	CbGeAlD
Vismodegib—Weight decreased—Mitoxantrone—multiple sclerosis	0.000514	0.00597	CcSEcCtD
Vismodegib—Arthralgia—Cladribine—multiple sclerosis	0.000513	0.00596	CcSEcCtD
Vismodegib—Myalgia—Cladribine—multiple sclerosis	0.000513	0.00596	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00051	0.00591	CcSEcCtD
Vismodegib—Alopecia—Azathioprine—multiple sclerosis	0.000498	0.00577	CcSEcCtD
Vismodegib—Nervous system disorder—Cladribine—multiple sclerosis	0.000482	0.0056	CcSEcCtD
Vismodegib—Skin disorder—Cladribine—multiple sclerosis	0.000478	0.00555	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000477	0.00554	CcSEcCtD
Vismodegib—ABCG2—medulla oblongata—multiple sclerosis	0.000457	0.0147	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000448	0.0052	CcSEcCtD
Vismodegib—Breast disorder—Methylprednisolone—multiple sclerosis	0.000448	0.00519	CcSEcCtD
Vismodegib—Decreased appetite—Cladribine—multiple sclerosis	0.000428	0.00496	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000425	0.00493	CcSEcCtD
Vismodegib—Fatigue—Cladribine—multiple sclerosis	0.000424	0.00492	CcSEcCtD
Vismodegib—Constipation—Cladribine—multiple sclerosis	0.000421	0.00488	CcSEcCtD
Vismodegib—Pain—Cladribine—multiple sclerosis	0.000421	0.00488	CcSEcCtD
Vismodegib—ABCG2—midbrain—multiple sclerosis	0.000418	0.0135	CbGeAlD
Vismodegib—Myalgia—Azathioprine—multiple sclerosis	0.000417	0.00484	CcSEcCtD
Vismodegib—Arthralgia—Azathioprine—multiple sclerosis	0.000417	0.00484	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000414	0.00481	CcSEcCtD
Vismodegib—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00041	0.00476	CcSEcCtD
Vismodegib—Hypokalaemia—Betamethasone—multiple sclerosis	0.00041	0.00476	CcSEcCtD
Vismodegib—ABCG2—spinal cord—multiple sclerosis	0.000408	0.0131	CbGeAlD
Vismodegib—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000402	0.00467	CcSEcCtD
Vismodegib—Alopecia—Mitoxantrone—multiple sclerosis	0.000402	0.00467	CcSEcCtD
Vismodegib—Abdominal pain—Cladribine—multiple sclerosis	0.000389	0.00451	CcSEcCtD
Vismodegib—Skin disorder—Azathioprine—multiple sclerosis	0.000389	0.00451	CcSEcCtD
Vismodegib—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000388	0.0045	CcSEcCtD
Vismodegib—ALB—brain—multiple sclerosis	0.000384	0.0124	CbGeAlD
Vismodegib—Back pain—Mitoxantrone—multiple sclerosis	0.000383	0.00445	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000364	0.00423	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—multiple sclerosis	0.000357	0.00414	CcSEcCtD
Vismodegib—Asthenia—Cladribine—multiple sclerosis	0.000353	0.0041	CcSEcCtD
Vismodegib—Weight decreased—Dexamethasone—multiple sclerosis	0.000352	0.00409	CcSEcCtD
Vismodegib—Weight decreased—Betamethasone—multiple sclerosis	0.000352	0.00409	CcSEcCtD
Vismodegib—Pruritus—Cladribine—multiple sclerosis	0.000348	0.00404	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000345	0.00401	CcSEcCtD
Vismodegib—Arthralgia—Mitoxantrone—multiple sclerosis	0.000337	0.00391	CcSEcCtD
Vismodegib—Myalgia—Mitoxantrone—multiple sclerosis	0.000337	0.00391	CcSEcCtD
Vismodegib—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000337	0.00391	CcSEcCtD
Vismodegib—Diarrhoea—Cladribine—multiple sclerosis	0.000337	0.00391	CcSEcCtD
Vismodegib—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000327	0.0038	CcSEcCtD
Vismodegib—ABCG2—cerebellum—multiple sclerosis	0.000323	0.0104	CbGeAlD
Vismodegib—Abdominal pain—Azathioprine—multiple sclerosis	0.000316	0.00367	CcSEcCtD
Vismodegib—Skin disorder—Mitoxantrone—multiple sclerosis	0.000314	0.00364	CcSEcCtD
Vismodegib—Vomiting—Cladribine—multiple sclerosis	0.000313	0.00363	CcSEcCtD
Vismodegib—ABCB1—retina—multiple sclerosis	0.000312	0.01	CbGeAlD
Vismodegib—Rash—Cladribine—multiple sclerosis	0.00031	0.0036	CcSEcCtD
Vismodegib—Dermatitis—Cladribine—multiple sclerosis	0.00031	0.0036	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—multiple sclerosis	0.000307	0.00356	CcSEcCtD
Vismodegib—Malnutrition—Methylprednisolone—multiple sclerosis	0.000298	0.00346	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—multiple sclerosis	0.000296	0.00344	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000295	0.00342	CcSEcCtD
Vismodegib—Dysgeusia—Triamcinolone—multiple sclerosis	0.000293	0.0034	CcSEcCtD
Vismodegib—Nausea—Cladribine—multiple sclerosis	0.000292	0.00339	CcSEcCtD
Vismodegib—Back pain—Triamcinolone—multiple sclerosis	0.000289	0.00336	CcSEcCtD
Vismodegib—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000285	0.0033	CcSEcCtD
Vismodegib—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000281	0.00326	CcSEcCtD
Vismodegib—Fatigue—Mitoxantrone—multiple sclerosis	0.000279	0.00324	CcSEcCtD
Vismodegib—Pain—Mitoxantrone—multiple sclerosis	0.000277	0.00321	CcSEcCtD
Vismodegib—Constipation—Mitoxantrone—multiple sclerosis	0.000277	0.00321	CcSEcCtD
Vismodegib—Alopecia—Betamethasone—multiple sclerosis	0.000275	0.0032	CcSEcCtD
Vismodegib—Alopecia—Dexamethasone—multiple sclerosis	0.000275	0.0032	CcSEcCtD
Vismodegib—Diarrhoea—Azathioprine—multiple sclerosis	0.000274	0.00318	CcSEcCtD
Vismodegib—CYP2C8—brain—multiple sclerosis	0.00027	0.0087	CbGeAlD
Vismodegib—Connective tissue disorder—Prednisone—multiple sclerosis	0.000267	0.00309	CcSEcCtD
Vismodegib—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000264	0.00307	CcSEcCtD
Vismodegib—ABCG2—brain—multiple sclerosis	0.000263	0.00846	CbGeAlD
Vismodegib—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000256	0.00297	CcSEcCtD
Vismodegib—Myalgia—Triamcinolone—multiple sclerosis	0.000255	0.00295	CcSEcCtD
Vismodegib—Vomiting—Azathioprine—multiple sclerosis	0.000254	0.00295	CcSEcCtD
Vismodegib—Myalgia—Methylprednisolone—multiple sclerosis	0.000254	0.00295	CcSEcCtD
Vismodegib—Arthralgia—Methylprednisolone—multiple sclerosis	0.000254	0.00295	CcSEcCtD
Vismodegib—Rash—Azathioprine—multiple sclerosis	0.000252	0.00293	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000252	0.00293	CcSEcCtD
Vismodegib—Dermatitis—Azathioprine—multiple sclerosis	0.000252	0.00292	CcSEcCtD
Vismodegib—Alopecia—Prednisone—multiple sclerosis	0.00024	0.00278	CcSEcCtD
Vismodegib—CYP3A4—nervous system—multiple sclerosis	0.000239	0.00771	CbGeAlD
Vismodegib—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000239	0.00277	CcSEcCtD
Vismodegib—Nausea—Azathioprine—multiple sclerosis	0.000238	0.00276	CcSEcCtD
Vismodegib—Skin disorder—Methylprednisolone—multiple sclerosis	0.000236	0.00274	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—multiple sclerosis	0.000236	0.00274	CcSEcCtD
Vismodegib—Asthenia—Mitoxantrone—multiple sclerosis	0.000232	0.00269	CcSEcCtD
Vismodegib—Myalgia—Betamethasone—multiple sclerosis	0.000231	0.00268	CcSEcCtD
Vismodegib—Myalgia—Dexamethasone—multiple sclerosis	0.000231	0.00268	CcSEcCtD
Vismodegib—CYP3A4—central nervous system—multiple sclerosis	0.000231	0.00742	CbGeAlD
Vismodegib—Pain—Prednisolone—multiple sclerosis	0.000227	0.00263	CcSEcCtD
Vismodegib—ABCB1—medulla oblongata—multiple sclerosis	0.000226	0.00726	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000222	0.00258	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000222	0.00257	CcSEcCtD
Vismodegib—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000221	0.00257	CcSEcCtD
Vismodegib—Nervous system disorder—Betamethasone—multiple sclerosis	0.000217	0.00252	CcSEcCtD
Vismodegib—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000217	0.00252	CcSEcCtD
Vismodegib—Dyspepsia—Triamcinolone—multiple sclerosis	0.000215	0.00249	CcSEcCtD
Vismodegib—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000214	0.00249	CcSEcCtD
Vismodegib—Fatigue—Triamcinolone—multiple sclerosis	0.00021	0.00244	CcSEcCtD
Vismodegib—Fatigue—Methylprednisolone—multiple sclerosis	0.00021	0.00244	CcSEcCtD
Vismodegib—Pain—Triamcinolone—multiple sclerosis	0.000209	0.00242	CcSEcCtD
Vismodegib—ABCB1—midbrain—multiple sclerosis	0.000206	0.00664	CbGeAlD
Vismodegib—Vomiting—Mitoxantrone—multiple sclerosis	0.000206	0.00239	CcSEcCtD
Vismodegib—Rash—Mitoxantrone—multiple sclerosis	0.000204	0.00237	CcSEcCtD
Vismodegib—Dermatitis—Mitoxantrone—multiple sclerosis	0.000204	0.00236	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000202	0.00234	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000202	0.00234	CcSEcCtD
Vismodegib—ABCB1—spinal cord—multiple sclerosis	0.000201	0.00648	CbGeAlD
Vismodegib—Arthralgia—Prednisone—multiple sclerosis	0.000201	0.00233	CcSEcCtD
Vismodegib—Myalgia—Prednisone—multiple sclerosis	0.000201	0.00233	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—multiple sclerosis	0.0002	0.00233	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.0002	0.00232	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000199	0.00231	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—multiple sclerosis	0.000197	0.00229	CcSEcCtD
Vismodegib—Dyspepsia—Betamethasone—multiple sclerosis	0.000195	0.00226	CcSEcCtD
Vismodegib—Dyspepsia—Dexamethasone—multiple sclerosis	0.000195	0.00226	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—multiple sclerosis	0.000193	0.00224	CcSEcCtD
Vismodegib—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000192	0.00223	CcSEcCtD
Vismodegib—Decreased appetite—Betamethasone—multiple sclerosis	0.000192	0.00223	CcSEcCtD
Vismodegib—Decreased appetite—Dexamethasone—multiple sclerosis	0.000192	0.00223	CcSEcCtD
Vismodegib—Nausea—Mitoxantrone—multiple sclerosis	0.000192	0.00223	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000191	0.00222	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000191	0.00222	CcSEcCtD
Vismodegib—Back pain—Methotrexate—multiple sclerosis	0.000191	0.00222	CcSEcCtD
Vismodegib—Fatigue—Dexamethasone—multiple sclerosis	0.000191	0.00221	CcSEcCtD
Vismodegib—Fatigue—Betamethasone—multiple sclerosis	0.000191	0.00221	CcSEcCtD
Vismodegib—Pain—Betamethasone—multiple sclerosis	0.000189	0.0022	CcSEcCtD
Vismodegib—Pain—Dexamethasone—multiple sclerosis	0.000189	0.0022	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—multiple sclerosis	0.000189	0.00219	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—multiple sclerosis	0.000187	0.00217	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000181	0.0021	CcSEcCtD
Vismodegib—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000181	0.0021	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000176	0.00204	CcSEcCtD
Vismodegib—Asthenia—Triamcinolone—multiple sclerosis	0.000175	0.00203	CcSEcCtD
Vismodegib—Abdominal pain—Betamethasone—multiple sclerosis	0.000175	0.00203	CcSEcCtD
Vismodegib—Abdominal pain—Dexamethasone—multiple sclerosis	0.000175	0.00203	CcSEcCtD
Vismodegib—Asthenia—Methylprednisolone—multiple sclerosis	0.000175	0.00203	CcSEcCtD
Vismodegib—Pruritus—Triamcinolone—multiple sclerosis	0.000173	0.002	CcSEcCtD
Vismodegib—Pruritus—Methylprednisolone—multiple sclerosis	0.000172	0.002	CcSEcCtD
Vismodegib—Dyspepsia—Prednisone—multiple sclerosis	0.00017	0.00197	CcSEcCtD
Vismodegib—ABCB1—nervous system—multiple sclerosis	0.000169	0.00546	CbGeAlD
Vismodegib—Arthralgia—Methotrexate—multiple sclerosis	0.000168	0.00195	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—multiple sclerosis	0.000168	0.00195	CcSEcCtD
Vismodegib—Decreased appetite—Prednisone—multiple sclerosis	0.000168	0.00194	CcSEcCtD
Vismodegib—Rash—Prednisolone—multiple sclerosis	0.000167	0.00194	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—multiple sclerosis	0.000167	0.00194	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000167	0.00194	CcSEcCtD
Vismodegib—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000167	0.00193	CcSEcCtD
Vismodegib—Fatigue—Prednisone—multiple sclerosis	0.000166	0.00193	CcSEcCtD
Vismodegib—Constipation—Prednisone—multiple sclerosis	0.000165	0.00191	CcSEcCtD
Vismodegib—ABCB1—central nervous system—multiple sclerosis	0.000163	0.00525	CbGeAlD
Vismodegib—ABCB1—cerebellum—multiple sclerosis	0.000159	0.00514	CbGeAlD
Vismodegib—Asthenia—Dexamethasone—multiple sclerosis	0.000159	0.00184	CcSEcCtD
Vismodegib—Asthenia—Betamethasone—multiple sclerosis	0.000159	0.00184	CcSEcCtD
Vismodegib—Nervous system disorder—Methotrexate—multiple sclerosis	0.000158	0.00183	CcSEcCtD
Vismodegib—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000158	0.00183	CcSEcCtD
Vismodegib—Nausea—Prednisolone—multiple sclerosis	0.000158	0.00183	CcSEcCtD
Vismodegib—Pruritus—Betamethasone—multiple sclerosis	0.000157	0.00182	CcSEcCtD
Vismodegib—Pruritus—Dexamethasone—multiple sclerosis	0.000157	0.00182	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—multiple sclerosis	0.000157	0.00182	CcSEcCtD
Vismodegib—Vomiting—Triamcinolone—multiple sclerosis	0.000155	0.0018	CcSEcCtD
Vismodegib—Vomiting—Methylprednisolone—multiple sclerosis	0.000155	0.0018	CcSEcCtD
Vismodegib—Rash—Triamcinolone—multiple sclerosis	0.000154	0.00179	CcSEcCtD
Vismodegib—Dermatitis—Triamcinolone—multiple sclerosis	0.000154	0.00178	CcSEcCtD
Vismodegib—Rash—Methylprednisolone—multiple sclerosis	0.000153	0.00178	CcSEcCtD
Vismodegib—Dermatitis—Methylprednisolone—multiple sclerosis	0.000153	0.00178	CcSEcCtD
Vismodegib—Abdominal pain—Prednisone—multiple sclerosis	0.000152	0.00177	CcSEcCtD
Vismodegib—Diarrhoea—Betamethasone—multiple sclerosis	0.000151	0.00176	CcSEcCtD
Vismodegib—Diarrhoea—Dexamethasone—multiple sclerosis	0.000151	0.00176	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000147	0.0017	CcSEcCtD
Vismodegib—Nausea—Triamcinolone—multiple sclerosis	0.000145	0.00168	CcSEcCtD
Vismodegib—Nausea—Methylprednisolone—multiple sclerosis	0.000145	0.00168	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—multiple sclerosis	0.000142	0.00165	CcSEcCtD
Vismodegib—Vomiting—Dexamethasone—multiple sclerosis	0.000141	0.00163	CcSEcCtD
Vismodegib—Vomiting—Betamethasone—multiple sclerosis	0.000141	0.00163	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—multiple sclerosis	0.00014	0.00163	CcSEcCtD
Vismodegib—Rash—Betamethasone—multiple sclerosis	0.00014	0.00162	CcSEcCtD
Vismodegib—Rash—Dexamethasone—multiple sclerosis	0.00014	0.00162	CcSEcCtD
Vismodegib—Dermatitis—Dexamethasone—multiple sclerosis	0.000139	0.00162	CcSEcCtD
Vismodegib—Dermatitis—Betamethasone—multiple sclerosis	0.000139	0.00162	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000139	0.00161	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—multiple sclerosis	0.000139	0.00161	CcSEcCtD
Vismodegib—Asthenia—Prednisone—multiple sclerosis	0.000138	0.00161	CcSEcCtD
Vismodegib—Pain—Methotrexate—multiple sclerosis	0.000138	0.0016	CcSEcCtD
Vismodegib—Pruritus—Prednisone—multiple sclerosis	0.000136	0.00158	CcSEcCtD
Vismodegib—Diarrhoea—Prednisone—multiple sclerosis	0.000132	0.00153	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000132	0.00153	CcSEcCtD
Vismodegib—Nausea—Betamethasone—multiple sclerosis	0.000131	0.00153	CcSEcCtD
Vismodegib—Nausea—Dexamethasone—multiple sclerosis	0.000131	0.00153	CcSEcCtD
Vismodegib—ABCB1—brain—multiple sclerosis	0.00013	0.00417	CbGeAlD
Vismodegib—Abdominal pain—Methotrexate—multiple sclerosis	0.000127	0.00148	CcSEcCtD
Vismodegib—Vomiting—Prednisone—multiple sclerosis	0.000123	0.00142	CcSEcCtD
Vismodegib—Rash—Prednisone—multiple sclerosis	0.000122	0.00141	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—multiple sclerosis	0.000121	0.00141	CcSEcCtD
Vismodegib—Asthenia—Methotrexate—multiple sclerosis	0.000116	0.00134	CcSEcCtD
Vismodegib—Nausea—Prednisone—multiple sclerosis	0.000115	0.00133	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—multiple sclerosis	0.000114	0.00132	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—multiple sclerosis	0.00011	0.00128	CcSEcCtD
Vismodegib—Vomiting—Methotrexate—multiple sclerosis	0.000102	0.00119	CcSEcCtD
Vismodegib—Rash—Methotrexate—multiple sclerosis	0.000102	0.00118	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—multiple sclerosis	0.000101	0.00118	CcSEcCtD
Vismodegib—Nausea—Methotrexate—multiple sclerosis	9.57e-05	0.00111	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	9.53e-05	0.00118	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.35e-05	0.00116	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.35e-05	0.00116	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.22e-05	0.00114	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.22e-05	0.00114	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.18e-05	0.00114	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—ICAM1—multiple sclerosis	9.17e-05	0.00113	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCL5—multiple sclerosis	9.12e-05	0.00113	CbGpPWpGaD
Vismodegib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.1e-05	0.00113	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9e-05	0.00111	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9e-05	0.00111	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL4—multiple sclerosis	8.76e-05	0.00108	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCL5—multiple sclerosis	8.65e-05	0.00107	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	8.58e-05	0.00106	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	8.56e-05	0.00106	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.36e-05	0.00103	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL3—multiple sclerosis	8.33e-05	0.00103	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCR5—multiple sclerosis	8.22e-05	0.00102	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—CCL2—multiple sclerosis	8.21e-05	0.00102	CbGpPWpGaD
Vismodegib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.13e-05	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL2RA—multiple sclerosis	8.1e-05	0.001	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.07e-05	0.000999	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.02e-05	0.000993	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PTGER4—multiple sclerosis	8.02e-05	0.000993	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	7.93e-05	0.000982	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL3—multiple sclerosis	7.9e-05	0.000978	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PGR—multiple sclerosis	7.9e-05	0.000978	CbGpPWpGaD
Vismodegib—SHH—Disease—CD86—multiple sclerosis	7.82e-05	0.000968	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCR5—multiple sclerosis	7.79e-05	0.000964	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCR3—multiple sclerosis	7.75e-05	0.000959	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL2RA—multiple sclerosis	7.68e-05	0.000951	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CD28—multiple sclerosis	7.67e-05	0.00095	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	7.65e-05	0.000947	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PTGER4—multiple sclerosis	7.6e-05	0.000941	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCR2—multiple sclerosis	7.54e-05	0.000933	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PGR—multiple sclerosis	7.49e-05	0.000927	CbGpPWpGaD
Vismodegib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.41e-05	0.000917	CbGpPWpGaD
Vismodegib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.38e-05	0.000913	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCR3—multiple sclerosis	7.34e-05	0.000909	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	7.28e-05	0.000902	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CD28—multiple sclerosis	7.27e-05	0.0009	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.25e-05	0.000897	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCR2—multiple sclerosis	7.14e-05	0.000884	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.09e-05	0.000878	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IFNG—multiple sclerosis	6.98e-05	0.000863	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CNR1—multiple sclerosis	6.95e-05	0.000861	CbGpPWpGaD
Vismodegib—SHH—Disease—CCR5—multiple sclerosis	6.93e-05	0.000858	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SRM—multiple sclerosis	6.82e-05	0.000844	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.8e-05	0.000842	CbGpPWpGaD
Vismodegib—SHH—Disease—HLA-A—multiple sclerosis	6.76e-05	0.000836	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.7e-05	0.000829	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.69e-05	0.000828	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.69e-05	0.000828	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.65e-05	0.000823	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.65e-05	0.000823	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.61e-05	0.000818	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CNR1—multiple sclerosis	6.59e-05	0.000816	CbGpPWpGaD
Vismodegib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.59e-05	0.000815	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.52e-05	0.000807	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—POMC—multiple sclerosis	6.42e-05	0.000795	CbGpPWpGaD
Vismodegib—SHH—Disease—APOE—multiple sclerosis	6.31e-05	0.000781	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCL2—multiple sclerosis	6.29e-05	0.000778	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL10—multiple sclerosis	6.26e-05	0.000775	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL1B—multiple sclerosis	6.22e-05	0.00077	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL2—multiple sclerosis	6.2e-05	0.000767	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—POMC—multiple sclerosis	6.09e-05	0.000754	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.01e-05	0.000743	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.97e-05	0.000739	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.97e-05	0.000739	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.96e-05	0.000738	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCL2—multiple sclerosis	5.96e-05	0.000738	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLEK—multiple sclerosis	5.96e-05	0.000737	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL10—multiple sclerosis	5.94e-05	0.000735	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.84e-05	0.000723	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.8e-05	0.000717	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TYK2—multiple sclerosis	5.71e-05	0.000706	CbGpPWpGaD
Vismodegib—SHH—Disease—CD80—multiple sclerosis	5.7e-05	0.000706	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	5.55e-05	0.000687	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.54e-05	0.000686	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CD86—multiple sclerosis	5.48e-05	0.000678	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.45e-05	0.000674	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.45e-05	0.000674	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TYK2—multiple sclerosis	5.41e-05	0.00067	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.39e-05	0.000667	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL5—multiple sclerosis	5.39e-05	0.000667	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.29e-05	0.000655	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CD86—multiple sclerosis	5.19e-05	0.000642	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.16e-05	0.000638	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL5—multiple sclerosis	5.11e-05	0.000632	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SPP1—multiple sclerosis	4.99e-05	0.000618	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.94e-05	0.000612	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.89e-05	0.000605	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCR5—multiple sclerosis	4.86e-05	0.000601	CbGpPWpGaD
Vismodegib—SHH—Disease—TYK2—multiple sclerosis	4.82e-05	0.000596	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP27B1—multiple sclerosis	4.8e-05	0.000594	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP24A1—multiple sclerosis	4.8e-05	0.000594	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL2RA—multiple sclerosis	4.79e-05	0.000592	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL2—multiple sclerosis	4.75e-05	0.000588	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SPP1—multiple sclerosis	4.73e-05	0.000586	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.72e-05	0.000584	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.7e-05	0.000582	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.65e-05	0.000576	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCR5—multiple sclerosis	4.6e-05	0.00057	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL2RA—multiple sclerosis	4.54e-05	0.000561	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.52e-05	0.000559	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—multiple sclerosis	4.52e-05	0.000559	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL2—multiple sclerosis	4.5e-05	0.000557	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	4.48e-05	0.000554	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—APOE—multiple sclerosis	4.42e-05	0.000547	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPC5—multiple sclerosis	4.39e-05	0.000544	CbGpPWpGaD
Vismodegib—SHH—Disease—CD4—multiple sclerosis	4.35e-05	0.000539	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SRM—multiple sclerosis	4.23e-05	0.000523	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SRM—multiple sclerosis	4.21e-05	0.00052	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SELE—multiple sclerosis	4.2e-05	0.000519	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—APOE—multiple sclerosis	4.19e-05	0.000518	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—multiple sclerosis	4.15e-05	0.000513	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.08e-05	0.000505	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	4.02e-05	0.000498	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CD80—multiple sclerosis	3.99e-05	0.000494	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.98e-05	0.000493	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.96e-05	0.00049	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	3.95e-05	0.000489	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.92e-05	0.000485	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—POMC—multiple sclerosis	3.8e-05	0.00047	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CD80—multiple sclerosis	3.79e-05	0.000469	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SRM—multiple sclerosis	3.78e-05	0.000467	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL2—multiple sclerosis	3.71e-05	0.00046	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000456	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.67e-05	0.000454	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—multiple sclerosis	3.64e-05	0.000451	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—RRM1—multiple sclerosis	3.64e-05	0.00045	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—MAPK1—multiple sclerosis	3.63e-05	0.00045	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.6e-05	0.000446	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—POMC—multiple sclerosis	3.6e-05	0.000445	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.59e-05	0.000444	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.57e-05	0.000442	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL2—multiple sclerosis	3.52e-05	0.000436	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.5e-05	0.000433	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—MAPK1—multiple sclerosis	3.44e-05	0.000426	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SRM—multiple sclerosis	3.44e-05	0.000426	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.43e-05	0.000424	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TYK2—multiple sclerosis	3.37e-05	0.000417	CbGpPWpGaD
Vismodegib—SHH—Disease—STAT3—multiple sclerosis	3.37e-05	0.000417	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TYK2—multiple sclerosis	3.2e-05	0.000396	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.19e-05	0.000395	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.16e-05	0.000391	CbGpPWpGaD
Vismodegib—SHH—Disease—MYC—multiple sclerosis	3.13e-05	0.000388	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—multiple sclerosis	3.13e-05	0.000387	CbGpPWpGaD
Vismodegib—SHH—Disease—MAPK1—multiple sclerosis	3.06e-05	0.000379	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ITGA4—multiple sclerosis	3.03e-05	0.000376	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IFNB1—multiple sclerosis	3.01e-05	0.000373	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.98e-05	0.000369	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.98e-05	0.000369	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP27B1—multiple sclerosis	2.96e-05	0.000367	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP24A1—multiple sclerosis	2.96e-05	0.000367	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.91e-05	0.00036	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.9e-05	0.000358	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.9e-05	0.000358	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL2—multiple sclerosis	2.81e-05	0.000347	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—multiple sclerosis	2.79e-05	0.000346	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.73e-05	0.000337	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPC5—multiple sclerosis	2.71e-05	0.000335	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.66e-05	0.000329	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.66e-05	0.000329	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL2—multiple sclerosis	2.66e-05	0.000329	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—multiple sclerosis	2.66e-05	0.000329	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—multiple sclerosis	2.65e-05	0.000328	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.6e-05	0.000322	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000321	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000321	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—multiple sclerosis	2.52e-05	0.000312	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.43e-05	0.000301	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.43e-05	0.0003	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.43e-05	0.0003	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000294	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.37e-05	0.000293	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STAT3—multiple sclerosis	2.36e-05	0.000292	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.36e-05	0.000292	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—multiple sclerosis	2.36e-05	0.000291	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SRM—multiple sclerosis	2.27e-05	0.000281	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.26e-05	0.00028	CbGpPWpGaD
Vismodegib—ALB—Metabolism—RRM1—multiple sclerosis	2.25e-05	0.000278	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STAT3—multiple sclerosis	2.24e-05	0.000277	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.22e-05	0.000275	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—multiple sclerosis	2.19e-05	0.000272	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—multiple sclerosis	2.19e-05	0.000271	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK1—multiple sclerosis	2.15e-05	0.000266	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.1e-05	0.00026	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.1e-05	0.00026	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—BCHE—multiple sclerosis	2.09e-05	0.000259	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—multiple sclerosis	2.08e-05	0.000257	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—multiple sclerosis	2.07e-05	0.000257	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2RA—multiple sclerosis	2.07e-05	0.000257	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK1—multiple sclerosis	2.03e-05	0.000252	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.02e-05	0.000249	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000244	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.84e-05	0.000228	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000227	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.82e-05	0.000225	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.81e-05	0.000224	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.8e-05	0.000223	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.78e-05	0.00022	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.75e-05	0.000217	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.74e-05	0.000216	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.69e-05	0.000209	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—multiple sclerosis	1.65e-05	0.000204	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.6e-05	0.000198	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.6e-05	0.000198	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.56e-05	0.000194	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—multiple sclerosis	1.56e-05	0.000193	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.51e-05	0.000186	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.5e-05	0.000185	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.46e-05	0.000181	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.43e-05	0.000176	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.37e-05	0.00017	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.34e-05	0.000166	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.3e-05	0.000161	CbGpPWpGaD
Vismodegib—ALB—Metabolism—BCHE—multiple sclerosis	1.29e-05	0.00016	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOE—multiple sclerosis	1.26e-05	0.000156	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.23e-05	0.000152	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.22e-05	0.000152	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—multiple sclerosis	1.22e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.21e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000143	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.14e-05	0.000141	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.00014	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-05	0.000138	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000134	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000131	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—multiple sclerosis	9.85e-06	0.000122	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—multiple sclerosis	9.48e-06	0.000117	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK1—multiple sclerosis	9.3e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—multiple sclerosis	7.8e-06	9.66e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—multiple sclerosis	7.76e-06	9.6e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—multiple sclerosis	6.97e-06	8.62e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.96e-06	8.62e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—multiple sclerosis	6.8e-06	8.41e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—multiple sclerosis	6.7e-06	8.3e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—multiple sclerosis	6.67e-06	8.25e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—multiple sclerosis	6.35e-06	7.86e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—multiple sclerosis	6.11e-06	7.56e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—multiple sclerosis	5.98e-06	7.41e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—multiple sclerosis	5.84e-06	7.23e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—multiple sclerosis	5.46e-06	6.75e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—multiple sclerosis	5.46e-06	6.75e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—multiple sclerosis	5.32e-06	6.59e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—multiple sclerosis	4.97e-06	6.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—multiple sclerosis	4.19e-06	5.18e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—multiple sclerosis	3.6e-06	4.45e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—multiple sclerosis	3.28e-06	4.06e-05	CbGpPWpGaD
